Form EFFECT Alto Neuroscience, Inc.
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/27/2026
- S&P 500 ends lower; chips tumble and Moderna rallies
- SpaceX weighs Starlink mobile service to US consumers, FT reports
- U.S. chip stocks retreat after Apple price hikes stoke fears over AI trade
- Morgan Stanley flags Fed hike risk if unemployment drops below 4%
- UBS trims AI portfolio exposure to semis and hardware after recent rally
Stifel Positive on Alto Neuroscience (ANRO), PT $10, 'risk/reward here for the stock is favorable'
February 12, 2025 10:09 AM ESTStifel analyst Paul Matteis reiterated a Buy rating and $10.00 price target on Alto Neuroscience (NYSE: ANRO)
The analyst comments "Trading below cash, the ALTO-300 interim analysis this morning re-affirms that the risk/reward here for the stock is favorable, in our view.... More
